Literature DB >> 2600586

Mechanism of staphylococcal resistance to non-oxidative antimicrobial action of neutrophils: importance of pH and ionic strength in determining the bactericidal action of cathepsin G.

W M Shafer1, V C Onunka.   

Abstract

The staphylococcalcidal action of highly purified, enzymically inactive human lysosomal cathepsin G was studied. The bactericidal action of cathepsin G was optimal at pH 7.5 and was inhibited by NaCl; concentrations greater than 0.15 M NaCl completely inhibited killing of Staphylococcus aureus. Under optimal conditions (pH, temperature and NaCl concentration) the ED50 (effective dose) of cathepsin G against S. aureus strain 8325-4 was about 3.1 micrograms ml-1. Polymeric teichoic acid may serve as a binding site for cathepsin G by promoting electrostatic interactions since a mutant lacking this surface component exhibited enhanced resistance to the lethal action of cathepsin G, compared to the teichoic-acid-positive parental strain. These results suggest that (i) the ability of cathepsin G to kill intraphagosomal staphylococci may be regulated in part by the ionic strength of the environment and the pH of the maturing phagolysosome, and (ii) that strategies which retard acidification of the developing phagolysosome would promote the staphylococcalcidal action of cathepsin G.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600586     DOI: 10.1099/00221287-135-4-825

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  11 in total

Review 1.  Antibiotic proteins of human neutrophils.

Authors:  J K Spitznagel
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  HIF-1alpha expression regulates the bactericidal capacity of phagocytes.

Authors:  Carole Peyssonnaux; Vivekanand Datta; Thorsten Cramer; Andrew Doedens; Emmanuel A Theodorakis; Richard L Gallo; Nancy Hurtado-Ziola; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

3.  Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content.

Authors:  W M Shafer; F Hubalek; M Huang; J Pohl
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity.

Authors:  K T Miyasaki; A L Bodeau
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau; J Pohl; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

6.  Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa.

Authors:  K R Wasiluk; K M Skubitz; B H Gray
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G.

Authors:  Samuel Katzif; Damien Danavall; Samera Bowers; Jacqueline T Balthazar; William M Shafer
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Synthetic peptides of human lysosomal cathepsin G with potent antipseudomonal activity.

Authors:  W M Shafer; M E Shepherd; B Boltin; L Wells; J Pohl
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  In vitro killing of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. by human neutrophil cathepsin G and elastase.

Authors:  K T Miyasaki; A L Bodeau
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 10.  Cathepsin G: roles in antigen presentation and beyond.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; Bernhard O Boehm; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2009-11-11       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.